In this episode, Lucas and Luna explore how quantum computing is beginning to model biological systems at the molecular level, specifically protein folding and enzyme dynamics. They discuss a recent preprint from researchers at a consortium involving IBM Quantum and the University of Tokyo that used a 127-qubit processor to simulate a small protein's energy landscape with better accuracy than classical approximations. The conversation covers why biology is a natural fit for quantum advantage — because quantum systems and biological molecules both obey the laws of quantum mechanics — and the near-term implications for drug discovery and synthetic biology. No hype, just the real signal: current qubit counts can already outperform classical methods on specific biomolecular subroutines, even if full-scale protein folding is still years away. Lucas and Luna weigh the promise against the engineering reality, including error rates and the difficulty of encoding biological data into quantum circuits. A grounded look at where quantum meets life sciences in mid-2026.

#QuantumComputing #Biology #ProteinFolding #DrugDiscovery #IBMQuantum #UniversityOfTokyo #MolecularSimulation #QuantumBiology #EnzymeDynamics #BiomolecularModeling #QuantumAdvantage #ErrorCorrection #Qubits #SyntheticBiology #Technology #FexingoBusiness #BusinessPodcast #QuantumPodcast

Keep every episode free: buymeacoffee.com/fexingo